Reuters logo
2 months ago
BRIEF-Shire submits IND application for gene therapy candidate SHP654
July 6, 2017 / 11:16 AM / 2 months ago

BRIEF-Shire submits IND application for gene therapy candidate SHP654

July 6 (Reuters) - Shire Plc

* Shire submits investigational new drug application to FDA for gene therapy candidate SHP654 for treatment of Hemophilia A

* Shire Plc - Shire submits investigational new drug application to FDA for gene therapy candidate SHP654 for treatment of Hemophilia A Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below